Tyme Technologies, Inc. TYME NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

40/100

1/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

Tyme Technologies, Inc. (TYME) reported total assets of $88.02M and total liabilities of $7.93M for fiscal year 2022, resulting in total equity of $0.00.

The company held $74.35M in cash and short-term investments. Total debt stood at $37.33K, with net debt of $-13.7M.

Current ratio is 10.68, indicating strong short-term liquidity. Interest coverage is -363.2x (weak).

Criteria supported by this page:

HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
MOAT (28/100) — Total assets $88.02M and equity $0.00 support the company's competitive scale

Overall SharesGrow Score: 37/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score

40/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

HEALTH

67/100

Debt-to-Equity & liquidity

Proven by this page

✗

MOAT

28/100

→ Income

✓

GROWTH

65/100

→ Income

—

INCOME

N/A

No coverage

Tyme Technologies, Inc. Balance Sheet History

Metric	FY2022	FY2021	FY2020	FY2019
Total Assets	$88.02M	$110.26M	$29.5M	$17.52M
Total Liabilities	$7.93M	$8.47M	$10.48M	$7.85M
Total Debt	$37.33K	$75.91K	$572.79K	$597.34K
Cash & Investments	$74.35M	$107.52M	$26.7M	$14.3M
Total Stockholders Equity	$80.08M	$101.8M	$19.03M	$9.67M